Yissum Ltd. Introduces a Novel Method for Diagnosing Retinal Micro-Aneurysms to Prevent Diabetic Retinopathy
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
JERUSALEM--(BUSINESS WIRE)--Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., the technology transfer arm of the Hebrew University, introduces a novel method for detecting retinal micro-aneurysms that pose a high risk for leakage, an underlying cause of diabetic retinopathy. Diabetic retinopathy is a leading cause of blindness worldwide. The novel method will enable early diagnosis and treatment of the condition, potentially minimizing damage and saving vision. The technology was patented by Yissum, which is currently searching for an appropriate partner for the further development and commercialization of the invention. It was introduced at IATI-BioMed Israel 2013, the 12th National Life Science and Technology Week, held in the David InterContinental Hotel, Tel Aviv, Israel on June 10-12, 2013.
Help employers find you! Check out all the jobs and post your resume.
JERUSALEM--(BUSINESS WIRE)--Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., the technology transfer arm of the Hebrew University, introduces a novel method for detecting retinal micro-aneurysms that pose a high risk for leakage, an underlying cause of diabetic retinopathy. Diabetic retinopathy is a leading cause of blindness worldwide. The novel method will enable early diagnosis and treatment of the condition, potentially minimizing damage and saving vision. The technology was patented by Yissum, which is currently searching for an appropriate partner for the further development and commercialization of the invention. It was introduced at IATI-BioMed Israel 2013, the 12th National Life Science and Technology Week, held in the David InterContinental Hotel, Tel Aviv, Israel on June 10-12, 2013.
Help employers find you! Check out all the jobs and post your resume.